瑞銀料至明年初內地陸續有寬鬆政策出臺
瑞銀投資銀行亞太區主管及中國總裁金弘毅表示,近期中國經濟增長面臨壓力,主要是受疫情、限電和房地產行業影響,繼近期人行降準後,料到明年初爲止內地將陸續有寬鬆政策出臺,對整體經濟發展有信心。
對於美國證交會(SEC)確定連續三年未符合上市審計規則的外國公司需要退市,金弘毅表示,目前在美上市的中概股逾240只,總市值達9.2萬億元,當中17間佔總市值69%的公司已在香港二次上市,而未在香港上市但符合上市規則的公司約50多間,佔總市值約三成,料亦將陸續來港上市,屬於最平穩過渡方式。至於未符合港上市規則的有170多間,但市值只佔整體約2%,港交所明年或在上市規則作出調整,這些公司亦可能採取先下市方式,部分重組後再到港或內地科創版上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.